XTL Biopharmaceuticals Ltd. Recorded Big Gain
Fri, Mar 05, 2021 at 05:30 PM
XTL Biopharmaceuticals Ltd. (XTLB:NASDAQ) jumped higher at $3.75, a gain of 29.8%. On Thu 04 Mar 21, XTLB:NASDAQ hit a New 2-Week Low of $2.89. From Thu 18 Feb 21, the stock recorded 40.00% Up Days and 27.27% Green Days
The share price of the company has been moving sideways in recent weeks.
About XTL Biopharmaceuticals Ltd. (XTLB:NASDAQ)
XTL Biopharmaceuticals Ltd is engaged in the acquisition & development of pharmaceutical drugs for the treatment of unmet medical needs, currently for the treatment of schizophrenia and Hepatitis C. It has also developed a home therapeutic device.
Top 10 Gainers:
- Second Sight Medical Products, Inc. (EYES:NASDAQ), 304.9%
- Global Partner Acquisition Corp. (GPAC:NASDAQ), 100%
- Sify Technologies Limited (SIFY:NASDAQ), 45.93%
- AMTD International Inc. (HKIB:NYSE), 36.55%
- XTL Biopharmaceuticals Ltd. (XTLB:NASDAQ), 29.76%
- Purple Innovation, Inc. (PRPL:NASDAQ), 27.94%
- Medley LLC NT 24 (MDLQ:NYSE), 26.41%
- Plus Therapeutics, Inc. (PSTV:NASDAQ), 25.56%
- TSHA (TSHA:NASDAQ), 25.47%
- Sunesis Pharmaceuticals, Inc. (SNSS:NASDAQ), 24.3%